Patents by Inventor Christopher Tudan

Christopher Tudan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CXCR4 antagonist treatment of hematopoietic cells
    Publication number: 20060014682
    Abstract: In accordance with various aspects of the invention, CXCR4 antagonists may be used to treat hematopoietic cells, such as progenitor or stem cells, to promote the rate of cellular multiplication, self-renewal, proliferation or expansion. CXCR4 antagonists may be used therapeutically to stimulate hematopoietic stem/progenitor cell multiplication/self-renewal.
    Type: Application
    Filed: September 20, 2004
    Publication date: January 19, 2006
    Applicants: Chemokine Therapeutics Corporation, The University of British Columbia
    Inventors: Christopher Tudan, Ahmed Merzouk, Lakhdar Arab, Geeta Saxena, Connie Eaves, Joanne Cashman, Ian Clark-Lewis, Hassan Salari, Michael Clark-Lewis